J Nehme, M Abi Karam, C Haber, N G Hanna, R Farhat, M Sahyoun, A Schakal, A Samaha, G Azar, A Jalkh
PURPOSE: To investigate the beneficial effect of bevacizumab injection one week prior to panretinal photocoagulation (PRP) on the occurrence of vitreous hemorrhage (VH) following PRP in high-risk proliferative diabetic retinopathy (PDR). METHODS: This was a case-control pilot study conducted on two groups: an anti-VEGF treatment group, treated with bevacizumab injection one week prior to the first PRP session, and a control group of treatment-naive PDR patients who underwent PRP treatment and were not given an intravitreal bevacizumab injection, consecutively recruited...
October 11, 2023: Journal Français D'ophtalmologie